|Other Names||Prostate collagen triple helix protein, C1QTNF9B antisense RNA 1, C1QTNF9B antisense gene protein 1, C1QTNF9B-AS1, PCOTH|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May be involved in growth and survival of prostate cancer cells through the TAF-Ibeta pathway.|
|Tissue Location||Expressed in prostate and testis. Weakly or not expressed in other tissues. Overexpressed in prostate cancers EMBL; BC015452; -; NOT_ANNOTATED_CDS; mRNA EMBL; AB113650; BAD93185.1; -; mRNA RefSeq; NP_001014442.2; NM_001014442.2 UniGene; Hs.642624; - ProteinModelPortal; Q58A44; - BioGrid; 139079; 1 IntAct; Q58A44; 1 STRING; 9606.ENSP00000396192; - BioMuta; PCOTH; - PaxDb; Q58A44; - PRIDE; Q58A44; - GeneID; 542767; - KEGG; hsa:542767; - CTD; 542767; - DisGeNET; 542767; - GeneCards; C1QTNF9B-AS1; - HGNC; HGNC:39839; C1QTNF9B-AS1 neXtProt; NX_Q58A44; - eggNOG; ENOG410JCC7; Eukaryota eggNOG; ENOG41114ZV; LUCA HOGENOM; HOG000169380; - InParanoid; Q58A44; - PhylomeDB; Q58A44; - BioCyc; ZFISH:G66-31917-MONOMER; - GenomeRNAi; 542767; - PRO; PR:Q58A44; - Proteomes; UP000005640; Unplaced GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell 1: Evidence at protein level; Complete proteome; Cytoplasm; Reference proteome CHAIN 1 107 Prostate collagen triple helix protein /FTId=PRO_0000337141 COMPBIAS 35 107 Pro-rich SEQUENCE 107 AA; 10968 MW; B738A5D9E95AF097 CRC64; MWILSNLMGT SEEGNLLSTV SPTVKALFGK TRVSPIFPFS PRSPFQPLIP RTPGSPWGPV GPASPLGPGF PIGPMGPGKP VGPKGPMLPL GPSGPVGPTS PLFPFCP|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
May be involved in growth and survival of prostate cancer cells through the TAF-Ibeta pathway.
Anazawa, Y., et al. Cancer Res. 65(11):4578-4586(2005)
If you have any additional inquiries please email technical services at email@example.com.